Cellyan Biotechnology Co., Ltd (HKPD) stock
HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
$1.52−0.09 (-5.30%)
Close on Nov 17, 2026Market cap $24.93MP/E –Yield –
Cellyan Biotechnology ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2026 it was -$2.30M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$2.30M | – |
| FY2025 | Mar 31, 2025 | -$2.21M | – |
| FY2024 | Mar 31, 2024 | -$1.89M | – |
| FY2023 | Mar 31, 2023 | -$1.72M | – |
See a number that looks wrong?